arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

VERACYTE, INC.

VCYT
$47.21 ▲ +1.08 (+2.34%) at close
Healthcare ·Services-Medical Laboratories ·USServices-Medical Laboratories
16 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
67
Health
Good
Neutral
auto_awesome

Analytical Summary

VERACYTE, INC. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $3.7B
Dividend Yield
Revenue Growth 16.0%
Op. Margin 11.2%
ROIC 4.3%
FCF / Share $1.61
Trailing P/E 56.2x
Price / Book 2.9x
FCF Yield 3.4%
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

16-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$517.14M
↑ +16.0%
Net Income Profit after all expenses
$66.35M
↑ +174.9%
Operating Margin Operating profit as % of sales
11.2%
↑ +208.5% 59th
FCF / Share Free cash flow per share
$1.61
↑ +93.1%
Long-Term Debt Long-term obligations
$0.00
↓ -100.0%

Health Breakdown

Profitability
72
Returns
54
Cash Quality
85

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 16 years · 58 quarters